John M. DeWitt

John M. DeWitt

Auto-generated profile, based on publicly available information

John M. DeWitt

Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Annals of Surgery
Verified
Journal Article
Open access
MNMarina N. Nikiforova
Marina N. Nikiforova
AWAbigail I. Wald
Abigail I. Wald
DSDaniel M. Spagnolo
Daniel M. Spagnolo
MMMelissa A. Melan
Melissa A. Melan
MGMaria Grupillo
Maria Grupillo
ASAatur D. Singhi
Aatur D. Singhi
Objective: We report the development and validation of a combined DNA/RNA next-generation sequencing (NGS) platform to improve the evaluation of pancreatic cysts. Background and Aims: Despite a multidisciplinary approach, pancreatic cyst classification, such as a cystic precursor neoplasm, and the detection of high-grade dysplasia and early adenocarcinoma (advanced neoplasia) can be challenging. NGS of preoperative pancreatic cyst fluid improves the clinical evaluation of pancreatic cysts, but the recent identification of novel genomic alterations necessitates the creation of a comprehensive panel and the development of a genomic classifier to integrate the complex molecular results. Methods: An updated and unique 74-gene DNA/RNA-targeted NGS panel (PancreaSeq Genomic Classifier) was created to evaluate 5 classes of genomic alterations to include gene mutations (e.g., KRAS, GNAS, etc.), gene fusions and gene expression. Further, CEA mRNA (CEACAM5) was integrated into the assay using RT-qPCR. Separate multi-institutional cohorts for training (n=108) and validation (n=77) were tested, and diagnostic performance was compared to clinical, imaging, cytopathologic, and guideline data. Results: Upon creation of a genomic classifier system, PancreaSeq GC yielded a 95% sensitivity and 100% specificity for a cystic precursor neoplasm, and the sensitivity and specificity for advanced neoplasia were 82% and 100%, respectively. Associated symptoms, cyst size, duct dilatation, a mural nodule, increasing cyst size, and malignant cytopathology had lower sensitivities (41–59%) and lower specificities (56–96%) for advanced neoplasia. This test also increased the sensitivity of current pancreatic cyst guidelines (IAP/Fukuoka and AGA) by >10% and maintained their inherent specificity. Conclusions: PancreaSeq GC was not only accurate in predicting pancreatic cyst type and advanced neoplasia but also improved the sensitivity of current pancreatic cyst guidelines.

1 May 2014 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
AKArslan Kahloon
Arslan Kahloon
NCNaga Chalasani
Naga Chalasani
JDJohn DeWitt
John DeWitt
SLSuthat Liangpunsakul
Suthat Liangpunsakul
RVRakesh Vinayek
Rakesh Vinayek
MCMichael Chiorean
Michael Chiorean

1 January 2022 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
JDJohn M. DeWitt
John M. DeWitt
RSRobert Siwiec
Robert Siwiec
WKWilliam R. Kessler
William R. Kessler
JWJohn M. Wo
John M. Wo
SSSarah Stainko
Sarah Stainko
MAMohamad A. Al-Haddad
Mohamad A. Al-Haddad

3 October 2022 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
YSYara Sarkis
Yara Sarkis
MAMohammad A Al-Haddad
Mohammad A Al-Haddad
RSRobert Siwiec
Robert Siwiec
WKWilliam R Kessler
William R Kessler
JWJohn M Wo
John M Wo
JDJohn M DeWitt
John M DeWitt
Summary: There are limited data on the safety of same-day discharge (SDD) after peroral endoscopic myotomy (POEM). The aim of our study is to assess the frequency and relationship to POEM for emergency department (ED) visits and hospitalizations after SDD in these patients. We retrospectively identified consecutive patients between November 2019 and August 2021 who underwent POEM with SDD and at least 6 months follow-up. Criteria for SDD includes: (1) no serious procedure-related adverse event; (2) post-POEM esophagram without leak; (3) stable vital signs; (4) ability to take liquids orally; (5) pain controlled without IV analgesia; (6) adequate social support; (7) American Society of Anesthesiologists (ASA) class I–III. A causative relationship between POEM and ED visits and hospitalizations was assigned by consensus. Out of 185 POEMs performed, 78 (41.7%, 42M, mean 51±16 years) had SDD. Within 30 days of POEM, 8 ED visits occurred in 7/78 (9%) patients and 2 (25%) were considered related to POEM; hospitalization was required in 3 (38%). After 30 days, 11 ED visits occurred in 10/78 (12.8%) patients and 1 (9%) was considered related to POEM; hospitalization was required in 5 (45%). In this study of consecutive SDD patients after POEM, 3/19 (16%) ED visits and 2/8 (25%) hospitalizations within 6 months were considered related to the procedure. Therefore, eligible patients who follow and fulfill a strict protocol after POEM may be safely discharged the same day.

25 April 2022 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
JDJohn M. DeWitt
John M. DeWitt
WKWilliam R. Kessler
William R. Kessler
JWJohn M. Wo
John M. Wo
SSSarah Stainko
Sarah Stainko
APAnthony Perkins
Anthony Perkins
RSRobert Siwiec
Robert Siwiec
INTRODUCTION: There are limited data correlating symptoms with reflux episodes during pH studies after peroral endoscopic myotomy. METHODS: Consecutive patients who underwent POEM followed up ≥6 months later by 48-hour ambulatory wireless pH testing off antisecretory therapy were identified. Reflux symptom association was defined as symptom association probability >95%. RESULTS: The most frequent symptoms of heartburn (47.2%), cough (45.1%), and chest pain (39.6%) were associated with a positive reflux symptom association (symptom association probability >95%) in 20.9%, 17.1%, and 19.4%, respectively. DISCUSSION: There is poor correlation between reported symptoms and esophageal acid exposure during pH testing after POEM.

21 November 2023 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
JDJohn M. DeWitt
John M. DeWitt
MAMohammad Al-Haddad
Mohammad Al-Haddad
SSSarah Stainko
Sarah Stainko
APAnthony Perkins
Anthony Perkins
HFHala Fatima
Hala Fatima
TBThomas J. Birdas
Thomas J. Birdas
Background and study aims Gastroesophageal reflux disease (GERD) following peroral endoscopic myotomy (POEM) occurs in 40% to 60% of patients. There are limited data evaluating antireflux surgery or transoral incisionless fundoplication (TIF) for refractory post-POEM GERD. Patients and methods In a single-center prospective cohort study, consecutive patients with medically refractory post-POEM regurgitation and/or GERD treated with TIF or combined laparoscopic hernia repair and TIF (cTIF) were evaluated. Baseline evaluation: GERD-Health Related Quality of Life (GERD-HQRL) and Reflux Symptom Questionnaire 7-day recall (RESQ-7) questionnaires, EGD, high-resolution manometry (HRM), 48-hour pH test off proton pump inhibitors (PPIs) and impedance planimetry of the esophagogastric junction (EGJ) to calculate the diameter distensibility index (EGJ-DI). A PPI was taken twice daily for 2 weeks after TIF and restarted later if required. Patients returned 9 to 12 months after treatment when all preoperative studies were repeated. Quality of life, pH studies and EGJ metrics before and after antireflux surgery were compared. Results Seventeen patients underwent TIF (n=2, 12%) or cTIF (n=15, 88%) a mean 25±15 months after POEM. At follow-up a mean of 9±1 months after TIF/cTIF, patients required less frequent daily PPIs (n=0.001), were more satisfied (P=0.008), had improved GERD-HQRL (P=0.001), less intensity and frequency of GERD (P=0.001) and fewer reflux episodes (P=0.04) by pH testing. There was no change in EGJ-DI, EGJ diameter, integrated relaxation pressure, % total time pH <4, or DeMeester score. Conclusions TIF and cTIF for difficult-to-control post-POEM GERD appear safe, decrease PPI use and reflux episodes, and improve QOL without significant change in IRP, EGJ compliance, diameter or esophageal acid exposure time.